Table 5.
Clinical outcomes for ovarian cancer patients
| Patient no. |
Age | No. prior chemo regimens |
Time since last chemo (months) |
Baseline CEA (ng/mL) |
Baseline CA-125 (U/mL) |
Best response |
PFS (months) |
OS (months) |
|---|---|---|---|---|---|---|---|---|
| 20 | 60 | 7 | 1 | 15 | 17333 | PD | 1 | 1.5 |
| 3 | 52 | 6 | 1 | <0.5 | 142 | PD | 1 | 2.4 |
| 11 | 70 | 3 | 1 | 1 | 1162 | PD | 2 | 11.6 |
| 15 | 55 | 7 | 1 | 1 | 277 | PD | 2 | 9.6 |
| 5 | 73 | 9 | 1 | 1.7 | 128 | PD | 2 | 35.0 |
| 6 | 54 | 7 | 2 | 1.3 | 117 | PD | 2 | 57.0+ |
| 14 | 57 | 1 | 13 | 0.8 | 115 | PD | 2 | 32.7 |
| 9 | 48 | 4 | 1 | 1.5 | 80 | PD | 2 | 15.0 |
| 7 | 45 | 2 | 3 | 1.2 | 11 | PD | 2 | 8.0 |
| 4 | 50 | 4 | 3 | 0.8 | 182 | PD | 3 | 41.9 |
| 18 | 57 | 5 | 6 | <0.5 | 592 | PD | 3 | 8.7 |
| 10 | 39 | 5 | 1 | 1 | 195 | SD | 4 | 29.3 |
| 2 | 56 | 4 | 4 | 0.5 | 46 | SD | 4 | 16.1 |
| 19 | 50 | 8 | 8 | 1.8 | 114 | SD | 6 | 40.5 |